首页>
外国专利>
Combination of a PD-l antagonist and a RAF inhibitor for treating cancer
Combination of a PD-l antagonist and a RAF inhibitor for treating cancer
展开▼
机译:PD-1拮抗剂和RAF抑制剂的组合用于治疗癌症
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed herein is a pharmaceutical combination for use in the prevention, delay of progression or treatment of cancer, wherein the pharmaceutical combination exhibits a synergistic efficacy. The pharmaceutical combination comprises a humanized antagonist monoclonal antibody against PD- and a RAF inhibitor. Also disclosed herein is a combination for use in the prevention, delay of progression or treatment of cancer in a subject, comprising administering to the subject a therapeutically effective amount of a humanized antagonist monoclonal antibody against PD-1 and a therapeutically effective amount of a RAF inhibitor.
展开▼